CNS Pharmaceuticals (CNSP) Insider Trading & Ownership $5.95 -0.84 (-12.37%) As of 03:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNS Pharmaceuticals (NASDAQ:CNSP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.07%Number OfInsiders Buying(Last 3 Years)3Number OfInsiders Selling(Last 3 Years)1 Get CNSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CNSP Insider Buying and Selling by Quarter CNS Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/22/2023Christopher DownsCFOBuy0$38,100.00$0.00 8/16/2023John M ClimacoCEOBuy0$54,000.00$0.00 4/19/2023Jerzy GumulkaDirectorBuy0$51,000.00$0.00 4/17/2023Christopher DownsCFOBuy0$96,000.00$0.00 4/12/2023John M ClimacoCEOBuy0$20,700.00$0.00 4/10/2023Jerzy GumulkaDirectorBuy0$22,200.00$0.00 3/27/2023Waldemar PriebeMajor ShareholderSell0$32,700.00$0.00 3/24/2023Waldemar PriebeMajor ShareholderSell0$32,400.00$0.00 3/22/2023Waldemar PriebeMajor ShareholderSell0$32,400.00$0.00 3/20/2023Waldemar PriebeMajor ShareholderSell0$32,400.00$0.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/17/2023Waldemar PriebeMajor ShareholderSell0$33,900.00$0.00 3/15/2023Waldemar PriebeMajor ShareholderSell0$36,600.00$0.00 3/13/2023Waldemar PriebeMajor ShareholderSell0$39,000.00$0.00 3/10/2023Waldemar PriebeMajor ShareholderSell0$38,700.00$0.00 (Data available from 1/1/2013 forward) CNSP Insider Trading Activity - Frequently Asked Questions Who is on CNS Pharmaceuticals' Insider Roster? The list of insiders at CNS Pharmaceuticals includes Christopher Downs, Jerzy Gumulka, John M Climaco, and Waldemar Priebe. Learn more on insiders at CNSP. What percentage of CNS Pharmaceuticals stock is owned by insiders? 0.07% of CNS Pharmaceuticals stock is owned by insiders. Learn more on CNSP's insider holdings. Which CNS Pharmaceuticals insiders have been buying company stock? The following insiders have purchased CNSP shares in the last 24 months: Christopher Downs ($0.00), and John M Climaco ($0.00). How much insider buying is happening at CNS Pharmaceuticals? Insiders have purchased a total of 0 CNSP shares in the last 24 months for a total of $0.00 bought. CNS Pharmaceuticals Key ExecutivesMr. John Michael Climaco Esq. (Age 55)J.D., CEO, President & Director Compensation: $525kMr. Christopher S. Downs CPA (Age 45)CTP, FP&A, Chief Financial Officer Compensation: $382.16kDr. Sandra L. Silberman M.D. (Age 68)Ph.D., Chief Medical Officer Compensation: $261.2kDr. Waldemar Priebe Ph.D.FounderDr. Donald H. Picker Ph.D. (Age 78)Chief Science Officer More Insider Trading Tools from MarketBeat Related Companies BFRG Insider Trading FLGC Insider Trading GOVX Insider Trading PHIO Insider Trading LGVN Insider Trading SONN Insider Trading HOOK Insider Trading BCDA Insider Trading IBIO Insider Trading SNSE Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried? This page (NASDAQ:CNSP) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access